FDA issued a Warning Letter to Algunas Inc., dba Woodland Hills Compounding Pharmacy on 7/17/2017 for a previous inspection.
483 Algunas, dba Woodland Hills Compounding Pharmacy Oct 2018

483 Algunas, dba Woodland Hills Compounding Pharmacy Oct 2018

Rumany Penn FDA$119.00 - Available Now

FDA investigators audited the Algunas, dba Woodland Hills Compounding Pharmacy - Woodland Hills, CA, United States facility and issued inspectional observations (via FDA 483) on 11 Oct 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Oct 2018
  • Location: Woodland Hills, United States
  • FEI: 3011830726
Add To Cart